These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 24005254)
1. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides. Shanks J; Herring N Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(12):R1411-20. PubMed ID: 24005254 [TBL] [Abstract][Full Text] [Related]
2. Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat. Shanks J; Manou-Stathopoulou S; Lu CJ; Li D; Paterson DJ; Herring N Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H980-6. PubMed ID: 23913706 [TBL] [Abstract][Full Text] [Related]
3. The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade. Kalla M; Hao G; Tapoulal N; Tomek J; Liu K; Woodward L; ; Dall'Armellina E; Banning AP; Choudhury RP; Neubauer S; Kharbanda RK; Channon KM; Ajijola OA; Shivkumar K; Paterson DJ; Herring N Eur Heart J; 2020 Jun; 41(23):2168-2179. PubMed ID: 31834357 [TBL] [Abstract][Full Text] [Related]
4. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. Herring N; Cranley J; Lokale MN; Li D; Shanks J; Alston EN; Girard BM; Carter E; Parsons RL; Habecker BA; Paterson DJ J Mol Cell Cardiol; 2012 Mar; 52(3):667-76. PubMed ID: 22172449 [TBL] [Abstract][Full Text] [Related]
5. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart. Kluge N; Dacey M; Hadaya J; Shivkumar K; Chan SA; Ardell JL; Smith C Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H66-H76. PubMed ID: 33095651 [TBL] [Abstract][Full Text] [Related]
6. Autonomic control of the heart: going beyond the classical neurotransmitters. Herring N Exp Physiol; 2015 Apr; 100(4):354-8. PubMed ID: 25344273 [TBL] [Abstract][Full Text] [Related]
8. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat. Smith-White MA; Wallace D; Potter EK J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119 [TBL] [Abstract][Full Text] [Related]
9. Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms. Alston EN; Parrish DC; Hasan W; Tharp K; Pahlmeyer L; Habecker BA Neuropeptides; 2011 Feb; 45(1):33-42. PubMed ID: 21035185 [TBL] [Abstract][Full Text] [Related]
10. Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats. Byku M; Macarthur H; Westfall TC Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2188-97. PubMed ID: 18835922 [TBL] [Abstract][Full Text] [Related]
11. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart. Ilebekk A; Björkman JA; Nordlander M J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Macarthur H; Westfall TC; Wilken GH Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H183-9. PubMed ID: 17965279 [TBL] [Abstract][Full Text] [Related]
13. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Li D; Wang L; Lee CW; Dawson TA; Paterson DJ Hypertension; 2007 Jul; 50(1):69-74. PubMed ID: 17515453 [TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function. Buttgereit J; Shanks J; Li D; Hao G; Athwal A; Langenickel TH; Wright H; da Costa Goncalves AC; Monti J; Plehm R; Popova E; Qadri F; Lapidus I; Ryan B; Özcelik C; Paterson DJ; Bader M; Herring N Cardiovasc Res; 2016 Dec; 112(3):637-644. PubMed ID: 27496871 [TBL] [Abstract][Full Text] [Related]
16. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Schömig A; Richardt G; Kurz T Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399 [TBL] [Abstract][Full Text] [Related]
17. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats. Vonend O; Okonek A; Stegbauer J; Habbel S; Quack I; Rump LC Cardiovasc Res; 2005 May; 66(2):345-52. PubMed ID: 15820203 [TBL] [Abstract][Full Text] [Related]
18. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Herring N; Tapoulal N; Kalla M; Ye X; Borysova L; Lee R; Dall'Armellina E; Stanley C; Ascione R; Lu CJ; Banning AP; Choudhury RP; Neubauer S; Dora K; Kharbanda RK; Channon KM; Eur Heart J; 2019 Jun; 40(24):1920-1929. PubMed ID: 30859228 [TBL] [Abstract][Full Text] [Related]
19. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide. Modin A Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]